GL1X · GenesisL1 explorer

Research workbench

Solution-state NMR structural ensemble of human TSG101 uev in complex with tenatoprazole

Analyse Solution-state NMR structural ensemble of human TSG101 uev in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VKG
Type
protein
Length
144 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tumor susceptibility gene 101 protein
UniProt
Q99816
Ligands
4N1
Pockets
1 · best druggability 0.42

Structure

solution nmr · 1 distinct chain · 26% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATumor susceptibility gene 101 proteinprotein14426% helix, 32% strandQ99816

Ligands and binding sites

  • 4N1 · 4-methoxy-1-(5-methoxy-3H-imidazo[4,5-b]pyridin-2-yl)-3,5-dimethyl-2-(sulfanylmethyl)pyridin-1-ium · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.420.8014empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5VKG · Solution-state NMR structural ensemble of human Tsg101 UEV in complex with tenatoprazole · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99816 · AlphaFold monomer V2.0 prediction for tumor susceptibility gene 101 protein (Q99816) · a predicted model of the same protein · chain A against A, TM-score 0.83

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.